Summit Therapeutics Inc.
NASDAQ: SMMT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Robert W. Duggan
- Employees
- 159
- Headquarters
- Cambridge, United States
- IPO year
- 2015
- Market cap
- $10.7B
- Website
- https://www.summittxinc.com
Loading SMMT…
Loading profile data…Frequently asked questions about SMMT
What does Summit Therapeutics Inc. (SMMT) do?
Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). It...
Where does SMMT trade?
Summit Therapeutics Inc. (SMMT) trades on the NASDAQ Global Market.
What sector is SMMT in?
Summit Therapeutics Inc. (SMMT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Summit Therapeutics Inc.?
Robert W. Duggan is the chief executive officer of Summit Therapeutics Inc. (SMMT).
Where is Summit Therapeutics Inc. headquartered?
Summit Therapeutics Inc. is headquartered in United States.
Does SMMT pay a dividend?
Summit Therapeutics Inc. (SMMT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SMMT go public?
Summit Therapeutics Inc. (SMMT) completed its initial public offering in 2015.